Th2 cytokines in susceptibility to tuberculosis

被引:0
作者
Rook, Graham A. W. [1 ]
机构
[1] UCL Royal Free & Univ Coll Med Sch, Windeyer Inst Med Sci, Ctr Infect Dis & Int Hlth, London W1T 4JF, England
关键词
IL-4; IL-4delta2; protective immunity; tuberculosis;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We need to understand what is different about susceptibility to tuberculosis (TB) in developing countries where most TB occurs, and where the current vaccine, Bacillus Calmette et Guerin (BCG) usually fails to protect. The presence of a background mixed IFN-gamma and Th2 response to mycobacterial antigens before infection with M. tuberculosis (Mtb), and the development of a large IL-4 response during progressive TB, are characteristics of individuals in the locations where BCG fails, which are also seen in animal models in the same countries. Recent data suggest that the background Th1 component in developing countries protects from low dose challenge with Mtb in mouse and man, but that following high dose challenge the pre-existing IL-4 component increases and blocks immunity unless the individual's immune system releases IL-4 delta 2, an antagonist of IL-4, which is raised in the blood of donors with stable latent TB. We outline how IL-4 (and IL-13) can undermine Th1-mediated immunity and drive inappropriate alternative activation of macrophages. The mechanisms of the effects of IL-4 include impaired antimicrobial activity due to reduced TNF-alpha-mediated apoptosis of infected cells, reduced activity of iNOS, increased availability of iron to intracellular Mtb, and increased proliferation of antigen-specific FOXP-3+ regulatory T cells. IL-4 also increases the toxicity of TNF-alpha and drives pulmonary fibrosis, thus enhancing immunopathology. The conclusion is that a vaccine that will work in developing countries might need to do more than enhance the existing Th1 response. In these environments it might be more important to block the Th2 component.
引用
收藏
页码:327 / 337
页数:11
相关论文
共 128 条
[31]   A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis [J].
Flores-Villanueva, PO ;
Ruiz-Morales, JA ;
Song, CH ;
Flores, LM ;
Jo, EK ;
Montaño, M ;
Barnes, PF ;
Selman, M ;
Granados, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (12) :1649-1658
[32]   Macrophage apoptosis in mycobacterial infections [J].
Fratazzi, C ;
Arbeit, RD ;
Carini, C ;
Balcewicz-Sablinska, MK ;
Keane, J ;
Kornfeld, H ;
Remold, HG .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (05) :763-764
[33]   Cloning of interleukin-4 delta2 splice variant (IL-4δ2) in chimpanzee and cynomolgus macaque:: phylogenetic analysis of δ2 splice variant appearance, and implications for the study of IL-4-driven immune processes [J].
Gautherot, I ;
Burdin, N ;
Seguin, D ;
Aujame, L ;
Sodoyer, R .
IMMUNOGENETICS, 2002, 54 (09) :635-644
[34]   RECOMBINANT HUMAN INTERLEUKIN-4 (IL-4) GIVEN AS DAILY SUBCUTANEOUS INJECTIONS - A PHASE-I DOSE TOXICITY TRIAL [J].
GILLEECE, MH ;
SCARFFE, JH ;
GHOSH, A ;
HEYWORTH, CM ;
BONNEM, E ;
TESTA, N ;
STERN, P ;
DEXTER, TM .
BRITISH JOURNAL OF CANCER, 1992, 66 (01) :204-210
[35]   Alternative activation of macrophages [J].
Gordon, S .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (01) :23-35
[36]   Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis [J].
Guyot-Revol, V ;
Innes, JA ;
Hackforth, S ;
Hinks, T ;
Lalvani, A .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (07) :803-810
[37]  
Harries AD, 2001, INT J TUBERC LUNG D, V5, P1000
[38]   Pulmonary tuberculosis in BALB/c mice with nonfunctional IL-4 genes:: changes in the inflammatory effects of TNF-α and in the regulation of fibrosis [J].
Hernandez-Pando, R ;
Aguilar, D ;
Hernandez, MLG ;
Orozco, H ;
Rook, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (01) :174-183
[39]   Interactions between hormone-mediated and vaccine-mediated immunotherapy for pulmonary tuberculosis in BALB/c mice [J].
Hernandez-Pando, R ;
Pavon, L ;
Orozco, EH ;
Rangel, J ;
Rook, GAW .
IMMUNOLOGY, 2000, 100 (03) :391-398
[40]   Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection [J].
HernandezPando, R ;
Pavon, L ;
Arriaga, K ;
Orozco, H ;
MadridMarina, V ;
Rook, G .
INFECTION AND IMMUNITY, 1997, 65 (08) :3317-3327